| Literature DB >> 36227876 |
Ana Lucia Seminario1,2, Arthur Kemoli3, Walter Fuentes4, Yan Wang5, Poojashree Rajanbabu6, Dalton Wamalwa7, Sarah Benki-Nugent2, Grace John-Stewart2,8,9, Jennifer A Slyker2,9.
Abstract
OBJECTIVES: The impact of antiretroviral treatment (ART) on the occurrence of oral diseases among children and adolescents living with HIV (CALHIV) is poorly understood. The aim of this study was to determine the effect of ART timing on vitamin D levels and the prevalence of four oral diseases (dry mouth, dental caries, enamel hypoplasia, and non-herpes oral ulcer) among Kenyan CALHIV from two pediatric HIV cohorts.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36227876 PMCID: PMC9560522 DOI: 10.1371/journal.pone.0275663
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Characteristics of children included in the oral diseases study.
| Variables | Combined cohort | Early (OPH cohort) | Late (PAD cohort) |
|---|---|---|---|
| (n = 78) | (n = 51) | (n = 27) | |
|
| |||
|
| |||
|
| 1 (0.4,2.9) | 0.4 (0.3,1) | 3.5 (2.6,5.1) |
|
| 11.4 (10.7,16.2) | 10.8 (10.4,11.3) | 17.1 (16,19.2) |
|
| |||
|
| 37 (47.4) | 22 (43.1) | 15 (55.6) |
|
| |||
|
| 51 (65.4) | 51 (100) | 0 (0) |
|
| 27 (34.6) | (0) | 27 (100) |
|
| 11 (10.1,13.4) | 10.4 (9.9,11) | 13.9 (12.9,14.3) |
|
| |||
| | 56(71.8) | 29(56.9) | 27(100) |
| | 22(28.2) | 22(43.1) | 0 (0) |
|
| 4.5(3.5,11.6) | 4.5(3.5,11.6) | NA |
|
| |||
|
| 1028 (516,1572) | 1326 (735,1757) | 522 (102,982) |
|
| 954 (681,1286) | 1059 (749,1370) | 764 (533,1269) |
|
| 39.5 (34,44) | 37 (33,43) | 41.5 (37.5,44) |
|
| |||
|
| 68 (87.2) | 47 (92.2) | 21 (77.8) |
|
| 6 (7.7) | 3 (5.9) | 3 (11.1) |
|
| 4 (5.1) | 1 (2) | 3 (11.1) |
|
| 10 (8,12) | 10 (8,12) | 10 (8,12) |
|
| 2 (1,2.5) | 2 (1,3) | 1 (1,2) |
*Nevirapine or efavirenz-based regimens,
**Lopinavir/ritonavir,
***TI = structured treatment interruption in the OPH cohort
Levels of vitamin D and oral diseases by ART initiation time.
| All children | Early-ART (OPH) | Late-ART (PAD) | P-value | |
|---|---|---|---|---|
|
|
| |||
|
| 27.1 ± 9.1 | 29.5 ± 9.3 | 22.4 ± 6.4 | 0.0002b |
|
| ||||
|
| 64 (82.1) | 46 (90.2) | 18 (66.7) | 0.01a |
|
| 14 (17.9) | 5 (9.8) | 9 (33.3) | |
|
| ||||
|
| 65 (83.3) | 42 (82.4) | 23 (85.2) | 0.2a |
|
| 53 (68) | 37 (72.6) | 16 (59.3) | 0.1a |
|
| 23 (29.5) | 17 (33.3) | 6 (22.2) | 0.1a |
|
| 7 (9) | 6 (11.8) | 1 (3.7) | 0.2a |
|
| 5 (6.4) | 4 (7.8) | 1 (3.7) | 0.3a |
|
| 2.6 ± 2.6 | 2.5 ± 2.4 | 2.8 ± 3 | 0.7b |
*Calculated using Fisher’s exact testa and two-sample t-testb
Fig 1Box plot of vitamin D level (ng/ml) by early- and late-ART initiation and by sex of children.
The middle line inside of the box is the median. The diamond inside of the box is the mean. The box represents the interquartile range (IQR, Q1 to Q3, from 25th percentile to 75th percentile). The upper and lower bars represent the Q1-1.5*IQR and Q3+1.5*IQR. The circles outside the bar could be potential outliers.
Association between vitamin D status (inadequate) and characteristics of Kenyan children on long-term ART (Risk Ratio (RR) and 95% confidence intervals (CI), both unadjusted and adjusted by age and sex).
| Characteristics | % Vitamin D Inadequate | Unadjusted RR | p-value | Adjusted RR | p-value |
|---|---|---|---|---|---|
|
| |||||
|
| 9.8% | 0.3 (0.1,0.8) | 0.0153 | 0.2 (0,1.4) | 0.0995 |
|
| 33.3% | ||||
|
| |||||
|
| 9.6% | 0.3 (0.1,0.7) | 0.0109 | ||
|
| 34.6% | ||||
|
| |||||
|
| 12.2% | 0.5 (0.2,1.4) | 0.1755 | ||
|
| 24.3% | ||||
|
| |||||
|
| 16.7% | 0.9 (0.1,5.9) | 0.9326 | 0.9 (0.2,3.6) | 0.8814 |
|
| 19.1% | ||||
|
| |||||
|
| 20.3% | 1.9 (0.5,7.9) | 0.3581 | 2 (0.5,8.1) | 0.3074 |
|
| 10.5% | ||||
|
| |||||
|
| 18.5% | 1.2 (0.3,4.7) | 0.7947 | 1 (0.2,4.3) | 0.9842 |
|
| 15.4% | ||||
|
| |||||
|
| 16.9% | 0.6 (0.2,2.1) | 0.4214 | 0.8 (0.2,2.7) | 0.7062 |
|
| 28.6% | ||||
|
| |||||
|
| 19.6% | 0.7 (0.2,2.3) | 0.5435 | 1.5 (0.4,6.4) | 0.5684 |
|
| 13.6% |
aCutoff age for adulthood in Kenya [35, 36]
bAdjusted for age and sex at the time of oral exam
Associations between serum vitamin D and oral diseases (Risk Ratio (RR) and 95% confidence intervals (CI), both unadjusted and adjusted by age).
| Oral disease | Vitamin D level | Unadjusted RR | Age adjusted RR | |||
|---|---|---|---|---|---|---|
| Any oral disease | Mean ± Std | Inadequate % | Risk ratio (RR) | p-value | adjusted RR | p-value |
|
| 27.3 ± 8.5 | 16.9% | 0.9 (0.7,1.2) | 0.6338 | 0.9 (0.7,1.2) | 0.5834 |
|
| 26.1 ± 12 | 23.1% | ||||
| Dental caries | ||||||
|
| 28.1 ± 8.8 | 15.1% | 0.8 (0.5,1.3) | 0.3978 | 0.8 (0.5,1.4) | 0.4743 |
|
| 24.8 ± 9.4 | 24% | ||||
| Dry mouth | ||||||
|
| 27 ± 6.6 | 17.4% | 1 (0.4,2.4) | 0.9342 | 1.1 (0.4,2.8) | 0.8589 |
|
| 27.1 ± 10 | 18.2% | ||||
| Enamel hypoplasia | ||||||
|
| 29.7 ± 7 | 14.3% | 0.8 (0.1,5.8) | 0.7935 | 1 (0.1,8.9) | 0.971 |
|
| 26.8 ± 9.2 | 18.3% | ||||
| Other ulcer (not HSV/aphthous) | ||||||
|
| 26.9 ± 3.3 | 0% | ||||
|
| 27.1 ± 9.3 | 19.2% | ||||
aRR was estimated by Poisson regression model, with early/late cohort as clustered effect. Both RR with and without age adjusted were reported in the table.